Related Experiment Video
Updated: Oct 24, 2026

Introduction of Intracapsular Rotary-cut Procedures (IRCP): A Modified Hysteromyomectomy Procedures Facilitating Fertility Preservation
Published on: January 17, 2019
GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal
D Wildemeersch1, I Batár, A Webb
1International Study Group on Intrauterine Drug Delivery, Dept of Ob/IGyn, University Hospital, Ghent, Belgium.
Abstract:
This article reviews the clinical experience with the GyneFix intrauterine implant system for interval, emergency and post-abortal contraception. The relatively high rate of unintended pregnancies and abortions in the world signifies that greater access to contraception is necessary. Unwanted pregnancies and abortions could be avoided by widening the range of effective and acceptable contraceptive methods for use in situations where current methods are far from optimal. High effectiveness, protection against sexual transmitted infections, long duration of action, reversibility and safety are some of the most important attributes of contraceptives valued by women. The development of the frameless intrauterine device is a response to the need to develop contraceptives with high user continuation rate. GyneFix has the lowest failure rate of all copper IUDs currently available. Its performance is further optimised by the atraumatic frameless design which minimises the side effects and discomfort experienced with conventional IUDs. GyneFix could, therefore, be a useful new contraceptive option in looking at ways to reduce the number of unwanted pregnacies and induced abortions.
Related Concept Videos
Intrauterine Drug Delivery Systems
Birth Control Methods
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices
In Vitro Fertilization
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
Modified-Release Drug Delivery Systems: Rate-Programmed I

